Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
In the latest session, Editas Medicine Inc (NASDAQ: EDIT) closed at $1.46 up 6.57% from its previous closing price of $1.37. In other words, the price has increased by $6.57 from its previous closing price. On the day, 1.67 million shares were traded. EDIT stock price reached its highest trading level at $1.5 during the session, while it also had its lowest trading level at $1.4.
Ratios:
For a deeper understanding of Editas Medicine Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.75 and its Current Ratio is at 3.75. In the meantime, Its Debt-to-Equity ratio is 0.26 whereas as Long-Term Debt/Eq ratio is at 0.15.
Stifel Downgraded its Buy to Hold on December 13, 2024, whereas the target price for the stock was revised from $11 to $3.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 04 ’25 when Lucera Erick sold 4,109 shares for $1.71 per share. The transaction valued at 7,030 led to the insider holds 112,720 shares of the business.
O’Neill Gilmore Neil sold 16,632 shares of EDIT for $28,452 on Mar 04 ’25. The CEO now owns 295,474 shares after completing the transaction at $1.71 per share. On Mar 04 ’25, another insider, Burkly Linda, who serves as the EVP, CHIEF SCIENTIFIC OFFICER of the company, sold 2,891 shares for $1.71 each. As a result, the insider received 4,946 and left with 70,245 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EDIT now has a Market Capitalization of 121145408 and an Enterprise Value of -113735624. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.75 while its Price-to-Book (P/B) ratio in mrq is 0.90. Its current Enterprise Value per Revenue stands at -3.52 whereas that against EBITDA is 0.488.
Stock Price History:
The Beta on a monthly basis for EDIT is 2.10, which has changed by -0.81088084 over the last 52 weeks, in comparison to a change of 0.09506309 over the same period for the S&P500. Over the past 52 weeks, EDIT has reached a high of $8.59, while it has fallen to a 52-week low of $1.12. The 50-Day Moving Average of the stock is -2.74%, while the 200-Day Moving Average is calculated to be -54.06%.
Shares Statistics:
For the past three months, EDIT has traded an average of 4.14M shares per day and 3200100 over the past ten days. A total of 82.73M shares are outstanding, with a floating share count of 82.23M. Insiders hold about 0.91% of the company’s shares, while institutions hold 62.52% stake in the company. Shares short for EDIT as of 1740700800 were 13766088 with a Short Ratio of 3.32, compared to 1738281600 on 17089279. Therefore, it implies a Short% of Shares Outstanding of 13766088 and a Short% of Float of 20.979999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
